Rapid Increase in Serum Levels of Matrix Metalloproteinase-9 (MMP-9) Postoperatively is Associated With a Decrease in the Amount of Intracellular MMP-9

Abstract

We have previously demonstrated a significant decrease in the serum concentration of intact insulin-like growth factor-binding protein (IGFBP-3) after laparotomy. IGFBP-3, a major IGF binding protein, inhibits the growth of tumor cells via several mechanisms. Our goal was to determine, in a murine model, whether matrix metalloproteinase-9 (MMP-9), a known protease of IGFBP-3, is responsible for the postoperative decrease in serum IGFBP-3 levels. Six IGFBP-3 transgenic mice on a CD-1 background were used in this study. These mice over-express human IGFBP-3. Sham laparotomy, in the form of a midline abdominal incision, was the test procedure. General anesthesia was established using ketamine and xylazine immediately before a 30-minute sham laparotomy and before preoperative blood sampling, done via retro-orbital venipuncture, 48 hours before surgery. The animals were sacrificed and blood was drawn 24 hours postoperatively. Plasma MMP-9 activity was measured using zymography at each time point (48 hours before and 24 hours after operation). MMP-9 activity was also measured in mononuclear cell lysates at both time points. Zymography analysis demonstrated significantly higher plasma levels of MMP-9 postoperatively compared with preoperative levels (81 RU vs 40 RU; P < .05). In contrast, mononuclear cell levels of MMP-9 were significantly higher preoperatively compared with postoperative levels (37.5 RU vs. 0.75 RU, P < .05). Plasma levels of MMP-9, a known protease of IGFBP-3, are significantly elevated postoperatively. In addition, mononuclear cells that store MMP-9 are depleted of it postoperatively. This suggests that rapid MMP-9 release by mononuclear cells leads to an increase in serum levels of this protease postoperatively. Further studies will elucidate mechanisms of MMP-9–related IGFBP-3 depletion.

Keywords

insulin-like growth factor-binding protein laparotomy matrix metalloproteinase-9 tumor growth

Get full access to this article

View all access options for this article.

References

Parkin DM , Pisani P , Ferlay J . Global cancer statistics. CA Cancer J Clin 49:33-64, 1999.

Vermoken JB , Claessen AM , van Tinteren H , et al: Active specific immunotherapy for stage 2 and stage 3 human colon cancer: a randomized trial. Lancet 353:345-350, 1999.

Jagoditsch M , Lisborg PH , Jatzgo GR , et al: Long-term prognosis for colon cancer related to consistent radical surgery: multivariate analysis of clinical, surgical and pathologic variables. World J Surg 24:1264-1270, 2000.

Weese JL , Ottery FD , Emoto SE : Do operations facilitate tumor growth? An experimental model in rats. Surgery 100:273-277, 1986.

Wildbrett P , Oh A , Carter JJ , et al: Increased rates of pulmonary metastases following sham laparotomy compared to CO2 pneumoperitoneum and the inhibition of metastases utilizing perioperative immunomodulation and a tumor vaccine. Surg Endosc 16:1162-1169, 2002.

Lee SW , Gleason N , Blanco I , et al: Higher colon cancer tumor proliferative index and lower tumor cell death rate in mice undergoing laparotomy versus insufflation. Surg Endosc 16:36-39, 2002.

Lee SW , Southall JC , Allendorf JD , et al: Tumor proliferative index is higher in mice undergoing laparotomy vs. CO2 pneumoperitoneum. Dis Colon Rectum 42:477-481, 1999.

Allendorf JD , Bessler M , Kayton ML , et al: Increased tumor establishment and growth after laparotomy vs laparoscopy in a murine model. Arch Surg 130:649-653, 1995.

Kirman I , Cekic V , Poltaratskaia N , et al: Plasma from patients undergoing major open surgery stimulates in vitro tumor growth: lower insulin-like growth factor binding protein 3 levels may, in part, account for this change. Surgery 132:186-192, 2002.

10.

Martin JL , Baxter RC : Insulin-like growth factor-binding protein from human plasma. Purification and characterization. J Biol Chem 261:8754-8760, 1986.

11.

Valentinis B , Bhala A , DeAngelis T , et al: The human insulin-like growth factor (IGF) binding protein-3 inhibits the growth of fibroblasts with a targeted disruption of the IGF-I receptor gene. Mol Endocrinol 9:361-367, 1995.

12.

Lee, HY , Chun, KH , Liu, B , et al: Insulin-like growth factorbinding protein-3 inhibits the growth of non–small cell lung cancer. Cancer Res 62: 3530-3537, 2002.

13.

Chambers AF , Matrisian LM : Changing views of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst 89:1260-1270, 1997.

14.

Waas ET , Wobbes T , Lomme RM et al: Matrix metalloproteinase 2 and 9 activity in patients with colorectal cancer liver metastasis. Br J Surg 90:1556-1564, 2003.

15.

Lee SW , Feingold DL , Carter JJ , et al: Peritoneal macrophage and blood monocyte functions after open and laparoscopic-assisted cecectomy in rats. Surg Endosc 17:1996-2002, 2003.

16.

Owen CA , Hu Z , Barrick B , Shapiro SD : Inducible expression of tissue inhibitor of metalloproteinases-resistant matrix metalloproteinase-9 on the cell surface of neutrophils. Am J Respir Cell Mol Biol 29:283-294, 2003.

17.

Allendorf JD , Bessler M , Horvath KD , et al: Increased tumor establishment and growth after open vs laparoscopic bowel resection in mice. Surg Endosc 12:1035-1038, 1998.

18.

Da Costa ML , Redmond P , Bouchier-Hayes DJ : The effect of laparotomy and laparoscopy on the establishment of spontaneous tumor metastases. Surgery 124:516-525, 1998.

19.

Carter JJ , Feingold DL , Kirman I , et al: Laparoscopicassisted cecectomy is associated with decreased formation of postoperative pulmonary metastases compared with open cecectomy in a murine model. Surgery 134:432-436, 2003.

20.

Lacy AM , Garcia-Valdecasas JC , Delgado S , et al: Laparoscopyassisted colectomy versus open colectomy for treatment of non metastatic colon cancer: a randomized trial. Lancet 359:2224-2229, 2002.

21.

Holmgren L , O’Reilly MS , Folkman J : Dormancy of micrometastases: balanced proliferation and apoptosis in the presence of angiogenesis suppression. Nat Med 1:149-153, 1995.

22.

O’reilly MS , Boehm T , Shing Y , et al: Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell 88:277-285, 1997.

23.

Kirman I , Poltoratskaia N , Sylla P , Whelan RL : Insulin-like growth factor-binding protein 3 inhibits growth of experimental colocarcinoma. Surgery 136:205-209, 2004.